These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 2458159)
1. Hydroxyethyl starch: an alternative to plasma for postoperative volume expansion after cardiac surgery. Munsch CM; MacIntyre E; Machin SJ; Mackie IJ; Treasure T Br J Surg; 1988 Jul; 75(7):675-8. PubMed ID: 2458159 [TBL] [Abstract][Full Text] [Related]
2. The haemostatic effects of hydroxyethyl starch (HES) used as a volume expander. Macintyre E; Mackie IJ; Ho D; Tinker J; Bullen C; Machin SJ Intensive Care Med; 1985; 11(6):300-3. PubMed ID: 2418087 [TBL] [Abstract][Full Text] [Related]
3. Avoidance of blood transfusion in coronary artery surgery: a trial of hydroxyethyl starch. Belcher P; Lennox SC Ann Thorac Surg; 1984 May; 37(5):365-70. PubMed ID: 6201145 [TBL] [Abstract][Full Text] [Related]
4. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840 [TBL] [Abstract][Full Text] [Related]
5. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Gallandat Huet RC; Siemons AW; Baus D; van Rooyen-Butijn WT; Haagenaars JA; van Oeveren W; Bepperling F Can J Anaesth; 2000 Dec; 47(12):1207-15. PubMed ID: 11132743 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Moggio RA; Rha CC; Somberg ED; Praeger PI; Pooley RW; Reed GE Crit Care Med; 1983 Dec; 11(12):943-5. PubMed ID: 6196155 [TBL] [Abstract][Full Text] [Related]
7. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin. Vogt NH; Bothner U; Lerch G; Lindner KH; Georgieff M Anesth Analg; 1996 Aug; 83(2):262-8. PubMed ID: 8694303 [TBL] [Abstract][Full Text] [Related]
8. Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Tigchelaar I; Gallandat Huet RC; Korsten J; Boonstra PW; van Oeveren W Eur J Cardiothorac Surg; 1997 Apr; 11(4):626-32. PubMed ID: 9151028 [TBL] [Abstract][Full Text] [Related]
9. Clinical comparison of hetastarch and albumin in postoperative cardiac patients. Diehl JT; Lester JL; Cosgrove DM Ann Thorac Surg; 1982 Dec; 34(6):674-9. PubMed ID: 6184023 [TBL] [Abstract][Full Text] [Related]
10. Hydroxyethyl starch versus albumin in cardiopulmonary bypass prime solutions. Saunders CR; Carlisle L; Bick RL Ann Thorac Surg; 1983 Nov; 36(5):532-9. PubMed ID: 6195981 [TBL] [Abstract][Full Text] [Related]
11. Influence of different volume therapies on platelet function in the critically ill. Boldt J; Müller M; Heesen M; Heyn O; Hempelmann G Intensive Care Med; 1996 Oct; 22(10):1075-81. PubMed ID: 8923073 [TBL] [Abstract][Full Text] [Related]
12. Comparison of a waxy maize and a potato starch-based balanced hydroxyethyl starch for priming in patients undergoing coronary artery bypass grafting. Sethi BS; Chauhan S; Bisoi AK; Kapoor PM; Kiran U; Rajput RS J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):690-7. PubMed ID: 24144628 [TBL] [Abstract][Full Text] [Related]
13. Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial. Lee MJ; Tannenbaum C; Mao G; Jia Y; Leung S; Yilmaz HO; Ince I; Soltesz E; Duncan AE Anesth Analg; 2021 Oct; 133(4):906-914. PubMed ID: 34406128 [TBL] [Abstract][Full Text] [Related]
14. Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Claes Y; Van Hemelrijck J; Van Gerven M; Arnout J; Vermylen J; Weidler B; Van Aken H Anesth Analg; 1992 Jul; 75(1):24-30. PubMed ID: 1377457 [TBL] [Abstract][Full Text] [Related]
15. The pharmacokinetics of acetyl starch as a plasma volume expander in patients undergoing elective surgery. Behne M; Thomas H; Bremerich DH; Lischke V; Asskali F; Förster H Anesth Analg; 1998 Apr; 86(4):856-60. PubMed ID: 9539615 [TBL] [Abstract][Full Text] [Related]
16. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Strauss RG; Pennell BJ; Stump DC Transfusion; 2002 Jan; 42(1):27-36. PubMed ID: 11896309 [TBL] [Abstract][Full Text] [Related]
17. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978 [TBL] [Abstract][Full Text] [Related]
18. HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial. Standl T; Lochbuehler H; Galli C; Reich A; Dietrich G; Hagemann H Eur J Anaesthesiol; 2008 Jun; 25(6):437-45. PubMed ID: 18339212 [TBL] [Abstract][Full Text] [Related]
19. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Ickx BE; Bepperling F; Melot C; Schulman C; Van der Linden PJ Br J Anaesth; 2003 Aug; 91(2):196-202. PubMed ID: 12878617 [TBL] [Abstract][Full Text] [Related]
20. Hydroxyethyl starch reduces coagulation competence and increases blood loss during major surgery: results from a randomized controlled trial. Rasmussen KC; Johansson PI; Højskov M; Kridina I; Kistorp T; Thind P; Nielsen HB; Ruhnau B; Pedersen T; Secher NH Ann Surg; 2014 Feb; 259(2):249-54. PubMed ID: 24100337 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]